Optometry Job Board

SAN FRANCISCO, CA—This month’s Ophthalmology , the journal of the American Academy of Ophthalmology, reports on use of bevacizumab (Avastin), to benefit diabetic patients with macular edema as well as people who develop cystoid macular edema after cataract surgery. Bevacizumab is also used to treat some cancers. Another study describes methods that could make cataract surgery safer for diabetic retinopathy (DR) patients. DR is the major threat to vision in working-age people, a problem that w

See the original post: 
Cancer treatment controls macular edema related to diabetes and to cataract surgery